ZSAN News
Archived Headlines
- Osteoporosis biotech Zosano Pharma sets terms for $33 million IPO 01/09/15
- Adhesive patch biotech Zosano Pharma postpones $70 million IPO 08/26/14
- One US IPO planned for the week of Aug 25 08/25/14
- 2 US IPOs planned for the week of Aug 18 08/18/14
- 4 US IPOs planned for the week of Aug 11 08/11/14
See more
US IPO Weekly Recap: Shake Shack and Spark spike over 100% in a week with 10 IPOs
Ten IPOs raised $1.2 billion in a week dominated by eight health care IPOs and distinguished by two deals that gained over 100% on the first day - fast casual burger chain Shake Shack and gene therapy biotech Spark Therapeutics. There were more health care IPOs...read more
Zosano Pharma prices IPO at $11 midpoint, one day after boosting deal size 43%
Zosano Pharma, which is developing a transdermal formulation of an approved osteoporosis treatment, raised $50 million on Tuesday by offering 4.5 million shares (upsized from 4.3 million shares) at $11, the midpoint of the range of $10 to $12. The day before,...read more
Zosano Pharma increases proposed IPO deal size by 43%; now expected to raise $47 million
Zosano Pharma, which is developing a transdermal formulation of an approved osteoporosis treatment, increased the proposed deal size for its upcoming IPO on Monday. The Fremont, CA-based company now plans to raise $47 million by offering 4.3 million shares...read more
Week ahead: IPO market gains momentum with 12 deals including Shake Shack and health care
Twelve IPOs are set to raise $1 billion in the upcoming week, which would make it the busiest five-day stretch for IPOs since the week of July 28. Shake Shack's IPO offers investors a chance to own a fast-growing fast casual concept based in New York. Ten of the...read more